Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care

Vera A. de Vries*, Marcella C. A. Mueller, M. Sesmu Arbous, Bart J. Biemond, Nicole Blijlevens, Nuray Kusadasi, Lambert R. F. Span, Alexander P. J. Vlaar, David J. van Westerloo, Hanneke C. Kluin-Nelemans, Walter M. van den Bergh, Pieter Roel Tuinman, Angelique Spoelstra, Erik Marijt, Murielle Hilkens, Jelle Epker, Annoek Broers, Goda Choi, Astrid Demandt, Walther van MookHEMA-ICU Study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E120-E128
Number of pages9
JournalCritical Care Medicine
Volume47
Issue number2
DOIs
Publication statusPublished - Feb 2019

Keywords

  • hematologic malignancy
  • intensive care unit
  • multiple organ failure/mortality
  • organ failure
  • prognosis
  • CRITICALLY-ILL PATIENTS
  • CANCER-PATIENTS
  • PROGNOSTIC-FACTORS
  • UNIT
  • ADMISSION
  • SEVERITY
  • CHEMOTHERAPY
  • SURVIVAL
  • IMPACT
  • GROUPE

Cite this